TrialLancet (London, England)2008

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Johannes F E Mann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.